CN1203804A - Ganbingkang medicine for curing liver disease - Google Patents
Ganbingkang medicine for curing liver disease Download PDFInfo
- Publication number
- CN1203804A CN1203804A CN98101811A CN98101811A CN1203804A CN 1203804 A CN1203804 A CN 1203804A CN 98101811 A CN98101811 A CN 98101811A CN 98101811 A CN98101811 A CN 98101811A CN 1203804 A CN1203804 A CN 1203804A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- herba
- rhizoma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 208000019423 liver disease Diseases 0.000 title claims abstract description 28
- 239000000843 powder Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 16
- 239000002775 capsule Substances 0.000 claims description 15
- 230000005389 magnetism Effects 0.000 claims description 10
- 208000034657 Convalescence Diseases 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 5
- 235000006667 Aleurites moluccana Nutrition 0.000 claims description 4
- 241001251068 Formica fusca Species 0.000 claims description 4
- 241000222336 Ganoderma Species 0.000 claims description 4
- 240000007049 Juglans regia Species 0.000 claims description 4
- 235000009496 Juglans regia Nutrition 0.000 claims description 4
- 241001530171 Luridae Species 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 244000286838 Eclipta prostrata Species 0.000 claims description 2
- 241000863503 Paederia Species 0.000 claims description 2
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 14
- 208000002672 hepatitis B Diseases 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 7
- 206010019799 Hepatitis viral Diseases 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 229940100691 oral capsule Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 7
- 241000700721 Hepatitis B virus Species 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000004863 Frankincense Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 206010019692 hepatic necrosis Diseases 0.000 description 2
- 230000007866 hepatic necrosis Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 235000004240 Triticum spelta Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000037890 multiple organ injury Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Ganbing Kangfu Chinese medicine prescription composition for curing liver diseases, including oral capsule preparation and magnetotherapeutic medicated bag for external application. Said invented medicine composition mainly is suitable for curing virus hepatitis A, B and C and liver diseases related to virus hepatitis. It can quickly obtain therapeutic result, and its therapeutic effect is reliable, toxic side effect is less and cost is low.
Description
The present invention relates to a kind of hepatopathy rehabilitation medicine, relate to a kind of medicine based on the treatment hepatitis B, particularly a kind of Chinese medicine and western medicine is in conjunction with the full presciption medicine thing of internal-external therapy.
Hepatitis B is caused by hepatitis B virus (HBV), becomes the master with liver, and can cause a kind of infectious disease of multiple organ injury.This disease is widely current all over the world, and at present, the whole world has more than 20 hundred million people to infect HBV, and China has 100,000,000 human hepatitis B surface antigen positives approximately.February nineteen eighty-three, World Health Organization (WHO) spelt out, and the cause of disease of 80% hepatocarcinoma has nearly 2,000,000 chronic carriers to die from liver cirrhosis or primary hepatocarcinoma that HBV causes owing to HBV causes every year.This shows that it is still very serious public health difficult problem to the world of present China that HBV infects, even to this day, the treatment of hepatitis B does not still have generally acknowledged effect method, is classified as one of 12 big medical science tackling key problem difficult problems by World Health Organization (WHO) so far.
Traditional rehabilitation principle of existing hepatitis B still with have a rest, nutrition is main means, is aided with suitable medicine and symptomatic treatment, doctor trained in Western medicine with protect the liver, antiviral, adjusting immunity; The traditional Chinese medical science with detoxifcation, dehumidifying, soothing liver-QI invigorate blood circulation, the spleen invigorating nourishing the liver; Above-mentioned treatment and known prior art are treated the Pharmaceuticals of such disease, the many unification of its means, its curative effect is not cut really, take effect slowly, the course of treatment long drug price costliness, the patient is difficult to adhere to for a long time taking medicine.
The object of the invention provides a kind of Ganbingkang medicine for curing liver disease, and this medicine adopts multiple, full presciption medicine thing that can inside and outside associating, this medicine treatment hepatitis B instant effect, short treating period, determined curative effect, drug price is low, and the patient can adhere to taking medicine for a long time, this medicine few side effects, supporting easy to use, be convenient to promote.
For achieving the above object, the present invention by the following technical solutions: a kind of Ganbingkang medicine for curing liver disease, it comprises: treatment by oral administration of medicines medicine and external treatment medicine, the treatment by oral administration of medicines medicine comprises: convalescence capsule for hepatosis patient; The external treatment medicine comprises: hepatopathy rehabilitation external medicine magnetism bag, wherein:
(1) convalescence capsule for hepatosis patient: each component proportioning (consumption is parts by weight) wherein
0.3～0.7 part of 0.2～0.6 part of Radix Kadsurae longipedunculatae of walnut tree root bark
0.2～0.6 part of 0.2～0.6 part of Fel Ursi powder of Radix Curcumae
0.3～0.7 part of 0.2～0.6 portion of Formica fusca of Rhizoma aspidistrae luridae
0.3～0.7 part of 0.2～0.6 part of Radix Et Caulis Acanthopanacis Senticosi of Ganoderma
(2) hepatopathy rehabilitation external medicine magnetism bag, wherein each component proportioning (consumption is parts by weight)
Magnetitum 80～120 Folium Citri tangerinae 2～6 Fructus Citri Sarcodactylis 3～5
Chinaberry 2～6 Radixs Linderae 2.5～5.5 Pericarpium Citri Reticulatae Virides 2～6
The Radix Paeoniae Alba 2～6 Rhizoma Cyperis 3～5 Radix Bupleuri 2～6
Flos Chrysanthemi 3～5 Herba Paederiaes 2～6 Fructus Foeniculi 2.5～5.5
Radix Et Rhizoma Rhei 3～5 Flos Carthamis 2～6 Olibanums 3～5
Myrrha 2.5～5.5 rhizoma sparganic 3～5 Rhizoma Curcumae 2～6
Rhizoma Chuanxiong 1.5～6.5 Radix Cynanchi Paniculatis 3～5 Radixs Astragali 2～6
Radix Angelicae Sinensis 3～5 Herba Ecliptaes 2～6 Herba Epimedii 1.5～6.5
Herba Lysimachiae 3～5 Herba Hedyotidis Diffusaes 2～6 Herba Taraxacis 3～5
Fructus Gardeniae 2～6 Rhizoma Paridis 2.5～5.5 Herba Artemisiae Scopariaes 3～5
Herba Pogostemonis 3～5 Herba Eupatoriis 2～6 Rhizoma Acori Graminei 3～5
The Radix Angelicae Dahuricae 2～6 Rhizoma Et Radix Notopterygiis 3～5 Folium Artemisiae Argyis 2.5～5.5
Borneolum Syntheticum 8～12 Mentholums 8～12 mature vinegar 40～92
The walnut tree root bark is the dry root bark of juglandaceae plant semen juglandis tree in the convalescence capsule for hepatosis patient.It is principal agent that this medical instrument has detoxicating, relieving inflammation; Radix Kadsurae longipedunculatae, Radix Curcumae, Fel Ursi have dispersing liver and promoting blood circulation, liver heat removing protects the liver and is accessory drugs; It is adjuvant drug that Formica fusca, Ganoderma, Radix Et Caulis Acanthopanacis Senticosi have enhance immunity; Rhizoma aspidistrae luridae has the repair tissue cell, is messenger drug.
The preparation technology of this capsule: every Chinese medicine difference decontamination in the general side, take by weighing in the desired amount, porphyrize is crossed 120 mesh sieves, will go into capsule according to a conventional method.If this capsule adopts modern decocting in water precipitate with ethanol or the heavy method of alcohol water intaking to extract effective ingredient and also is fine by the above the capsule preparation of any pharmaceutics.Raw material Fel Ursi powder used in this capsule can replace with natural Calculus Bovis or artificial Calculus Bovis, and the consumption umber proportioning in this medicine is: 015～0.35 (consumption is parts by weight), this medicine liver heat removing guarantees identical with Fel Ursi effect purposes.This capsule has: detoxicating, relieving inflammation, soothing the liverly protect the liver, enhance immunity, promotion hepatocyte recover.
Hepatopathy rehabilitation external medicine magnetism bag amounts to 39 flavor Chinese herbal medicine and forms, the effect of every medicine is respectively in the side: Magnetitum, Folium Citri tangerinae, Fructus Citri Sarcodactylis, Fructus Toosendan, the Radix Linderae, Pericarpium Citri Reticulatae Viride, the Radix Paeoniae Alba, Rhizoma Cyperi, Radix Bupleuri, Flos Chrysanthemi, Herba Paederiae, Fructus Foeniculi, has the liver microcirculation of improvement, alleviate hepatic necrosis, promote liver cell regeneration, enhance immunity, the circulation of qi promoting soothing liver-QI, pain relieving water inflammation is main medicine altogether, it is principal agent: Radix Et Rhizoma Rhei, Flos Carthami, Olibanum, Myrrha, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Chuanxiong, Radix Cynanchi Paniculati, the Radix Astragali, Radix Angelicae Sinensis, Herba Ecliptae, Herba Epimedii has blood circulation promoting and blood stasis dispelling, the compensate qi and blood negative and positive are ancillary drug, i.e. accessory drugs; Herba Lysimachiae, Herba Hedyotidis Diffusae, dandelion, Fructus Gardeniae, Rhizoma Paridis, Herba Artemisiae Scopariae, Herba Pogostemonis, Herba Eupatorii, Rhizoma Acori Graminei tool heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, removing dampness by means of aromatics are adjuvant drug altogether; The Radix Angelicae Dahuricae, Rhizoma Et Radix Notopterygii, Folium Artemisiae Argyi, Borneolum Syntheticum, Mentholum, mature vinegar have fragrance refreshes oneself, analgesia, warm liver easing the affected liver, the saturating flesh bone of antiinflammatory, and the effect of drawing the through sick institute of all medicines of external is messenger drug altogether.
The preparation technology of medicine magnetism bag:
1. Magnetitum (the Magnetitum the best of living) takes by weighing in the desired amount in the general side, and thin mistake 100 mesh sieves of powder are standby.
In the general side must amount mature vinegar (Shanxi mature vinegar the best) take out standby.
3. Olibanum, Myrrha, Borneolum Syntheticum, Mentholum take out in the desired amount in the general side, grind to the powder respectively, cross 100 mesh sieves, and be standby.
The cloth bag or the gauze bag of sewing it up is standby 4..
In the general side other every Chinese medicine respectively decontamination, take by weighing in the desired amount, 120 mesh sieves that ground to the powder altogether, standby.
6. at first mature vinegar in 2 is mixed with Chinese medicinal powder in 5 and the container that has sealing device of packing in place after 48 hours and take out the medicated powder drying, the back adds Magnetitum powder, frankincense powder, there is not medicated powder, in the Borneolum Syntheticum powder, the even bag of packing into of Mentholum powder blend, be worn on hepatic region or SHENQUE acupoint.
This external medicine magnetism bag has: improve liver microcirculation, alleviate hepatic necrosis, promote liver cell regeneration, enhance immunity, circulation of qi promoting soothing liver-QI, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, dampness removing jaundice eliminating, effects such as warm liver, nourishing the liver, easing the affected liver, anti-inflammatory analgesic.
Advantage of the present invention:
1. with organic conception, Chinese medicine and western medicine combination, inside and outside associating, administration simultaneously is that the theoretical direction thought of its rehabilitation and treatment is: the disease of all livers with prevention and health care, clinical, new medical science that rehabilitation three big medical science combine together, the first qi depression to blood stasis of working as, circulatory disturbance, stasis of blood resistance the liver pulse, malicious heresy is seized the opportunity invasion, the poison stasis of blood is cemented in liver and gall, the damage liver and gall, consumption is hindered healthy energy, so touching difficulty more.Internal-external therapy of the present invention, with promoting flow of QI and blood, the detoxifcation removing blood stasis, strengthening vital QI to eliminate pathogenic factors, the sick instant effect for the treatment of the liver, 7～14 days produce effects, after most of patients was treated a week, subjective symptoms disappeared substantially, and appetite is promoted, and is evident in efficacy.
2. this medicine is supporting easy, and is easy to use, and drug price is low, and painful few, side effect is little, and is safe and reliable, and the patient can adhere to taking medicine for a long time, is convenient to promote.
3. this medicine mainly is adapted to: first, second, the third three type viral hepatitis, be adapted to hepatitis B especially, and also can be used as because of the liver cirrhosis due to the hepatitis, the medicine of hepatopathys such as hepatocarcinoma.
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
Preparation convalescence capsule for hepatosis patient: get walnut tree root bark 0.4g, Radix Kadsurae longipedunculatae 0.5g, Radix Curcumae 0.4g, Fel Ursi powder 0.4g, Rhizoma aspidistrae luridae 0.4g, Formica fusca 0.5g, Ganoderma 0.4g, Radix Et Caulis Acanthopanacis Senticosi 0.5g, every medicine difference decontamination in the general side, grind to the powder, cross 120 mesh sieves, mixing, through 2 hours hard capsules of packing into of 35 ℃ of cold drying as convalescence capsule for hepatosis patient, if adopt (manually) Calculus Bovis 0.25g replacement Fel Ursi also to be fine; Preparation hepatopathy rehabilitation external medicine magnetism bag: get Magnetitum 100g, Folium Citri tangerinae 4g, Fructus Citri Sarcodactylis 4g, Fructus Toosendan 4g, Radix Linderae 4g, Pericarpium Citri Reticulatae Viride 4g, Radix Paeoniae Alba 4g, Rhizoma Cyperi 4g, Radix Bupleuri 4g, Flos Chrysanthemi 4g, Herba Paederiae 4g, Fructus Foeniculi 4g, Radix Et Rhizoma Rhei 4g, Flos Carthami 4g, Olibanum 4g, Myrrha 4g, rhizoma sparganic 4g, Rhizoma Curcumae 4g, Rhizoma Chuanxiong 4g, Radix Cynanchi Paniculati 4g, Radix Astragali 4g, Radix Angelicae Sinensis 4g, Herba Ecliptae 4g, Herba Epimedii 4g, Herba Lysimachiae 4g, Herba Hedyotidis Diffusae 4g, Herba Taraxaci 4g, Fructus Gardeniae 4g, Rhizoma Paridis 4g, Herba Artemisiae Scopariae 4g, Herba Pogostemonis 4g, Herba Eupatorii 4g, Rhizoma Acori Graminei 4g, Radix Angelicae Dahuricae 4g, Rhizoma Et Radix Notopterygii 4g, Folium Artemisiae Argyi 4g, Borneolum Syntheticum 10g, Mentholum 10g, mature vinegar 66g, prepare in the bag of packing into as hepatopathy rehabilitation external medicine magnetism bag by above-mentioned preparation method.
Medicine for external use in above-mentioned is supporting as Ganbingkang medicine for curing liver disease, be used for the treatment of three type viral hepatitis, liver cirrhosis, hepatocarcinoma, described interior medicine for external use is used, at first oral convalescence capsule for hepatosis patient is worn on hepatic region or SHENQUE acupoint with hepatopathy rehabilitation external medicine magnetism bag subsequently.
Claims (2)
1. Ganbingkang medicine for curing liver disease is characterized in that it comprises: treatment by oral administration of medicines medicine and external treatment medicine, and described treatment by oral administration of medicines medicine comprises: convalescence capsule for hepatosis patient; Described external treatment medicine comprises: hepatopathy rehabilitation external medicine magnetism bag, wherein:
(1) convalescence capsule for hepatosis patient: each component proportioning (consumption is parts by weight) wherein
0.3～0.7 part of 0.2～0.6 part of Radix Kadsurae longipedunculatae of walnut tree root bark
0.2～0.6 part of 0.2～0.6 part of Fel Ursi powder of Radix Curcumae
0.2～0.6 portion of Formica fusca 0.3～0.7 of Rhizoma aspidistrae luridae
0.3～0.7 part of 0.2～0.6 part of Radix Et Caulis Acanthopanacis Senticosi of Ganoderma
(2) hepatopathy rehabilitation external medicine magnetism bag: each component proportioning (consumption is parts by weight) wherein
Magnetitum 80～120 Folium Citri tangerinae 2～6 Fructus Citri Sarcodactylis 3～5
Fructus Toosendan 2～6 Radixs Linderae 2.5～5.5 Pericarpium Citri Reticulatae Virides 2～6
The Radix Paeoniae Alba 2～6 Rhizoma Cyperis 3～5 Radix Bupleuri 2～6
Flos Chrysanthemi 3～5 Herba Paederiaes 2～6 Fructus Foeniculi 2.5～5.5
Radix Et Rhizoma Rhei 3～5 Flos Carthamis 2～6 Olibanums 3～5
Myrrha 2.5～5.5 rhizoma sparganic 3～5 Rhizoma Curcumae 2～6
Rhizoma Chuanxiong 1.5～6.5 Radix Cynanchi Paniculatis 3～5 Radixs Astragali 2～6
Radix Angelicae Sinensis 3～5 Herba Ecliptaes 2～6 Herba Epimedii 1.5～6.5
Herba Lysimachiae 3～5 Herba Hedyotidis Diffusaes 2～6 Herba Taraxacis 3～5
Fructus Gardeniae 2～6 Rhizoma Paridis 2.5～5.5 Herba Artemisiae Scopariaes 3～5
Herba Pogostemonis 3～5 Herba Eupatoriis 2～6 Rhizoma Acori Graminei 3～5
The Radix Angelicae Dahuricae 2～6 Rhizoma Et Radix Notopterygiis 3～5 Folium Artemisiae Argyis 2.5～5.5
Borneolum Syntheticum 8～12 Mentholums 8～12 mature vinegar 40～92
2. according to the Ganbingkang medicine for curing liver disease described in claims 1; it is characterized in that: used raw material Fel Ursi powder can be (manually) bovine calculus powder in the described convalescence capsule for hepatosis patient, should the consumption parts by weight proportioning of (manually) bovine calculus powder in (1) be: 0.15～0.35.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98101811A CN1203804A (en) | 1998-05-04 | 1998-05-04 | Ganbingkang medicine for curing liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98101811A CN1203804A (en) | 1998-05-04 | 1998-05-04 | Ganbingkang medicine for curing liver disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1203804A true CN1203804A (en) | 1999-01-06 |
Family
ID=5216944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98101811A Pending CN1203804A (en) | 1998-05-04 | 1998-05-04 | Ganbingkang medicine for curing liver disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1203804A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101537061B (en) * | 2008-03-19 | 2011-03-16 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating liver cancer |
| CN102579909A (en) * | 2012-03-22 | 2012-07-18 | 胡爱民 | Medicament for treating chronic hepatitis |
| CN103736031A (en) * | 2014-01-23 | 2014-04-23 | 荆霞 | Drug for treating viral hepatitis type C and preparation method thereof |
| US8815221B2 (en) | 2009-08-06 | 2014-08-26 | Industrial Technology Research Institute | Composition used for skin whitening, plant extracted skin whitening composition and composition having a skin whitening effect |
| CN106334158A (en) * | 2016-10-17 | 2017-01-18 | 亳州学院 | Traditional Chinese medicine composition for treating virus hepatitis and preparation method thereof and application |
-
1998
- 1998-05-04 CN CN98101811A patent/CN1203804A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101537061B (en) * | 2008-03-19 | 2011-03-16 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating liver cancer |
| US8815221B2 (en) | 2009-08-06 | 2014-08-26 | Industrial Technology Research Institute | Composition used for skin whitening, plant extracted skin whitening composition and composition having a skin whitening effect |
| CN102579909A (en) * | 2012-03-22 | 2012-07-18 | 胡爱民 | Medicament for treating chronic hepatitis |
| CN102579909B (en) * | 2012-03-22 | 2013-07-10 | 胡爱民 | Medicament for treating chronic hepatitis |
| CN103736031A (en) * | 2014-01-23 | 2014-04-23 | 荆霞 | Drug for treating viral hepatitis type C and preparation method thereof |
| CN106334158A (en) * | 2016-10-17 | 2017-01-18 | 亳州学院 | Traditional Chinese medicine composition for treating virus hepatitis and preparation method thereof and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1322885C (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN103142920B (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN1203804A (en) | Ganbingkang medicine for curing liver disease | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN1095287A (en) | Abdominal protecting medicine for external use | |
| CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN103028049B (en) | Traditional Chinese medicine composition for treating tinea manuum and preparation method of composition | |
| CN1485086A (en) | Peroral Chinese medicine powder for treating bone fracture and its preparing process | |
| CN101322787B (en) | Specific medicinal liquor for treating rheumatoild disease | |
| CN1092970C (en) | Compound Chinese medicine for treating hepatocholepathy | |
| CN1294953C (en) | External Chinese materia medica preparation for treating leucoderma | |
| CN1294928C (en) | Traditional Chinese medicine pills for treating toothache, and its prepn. method | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN105797002A (en) | Traditional Chinese medicine composition for treating ichthyosis | |
| CN1772054A (en) | Liver softening plaster and its prepn | |
| CN101757355A (en) | Traditional Chinese medicine preparation for treating infertility | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism | |
| CN101716257A (en) | Orally taken powder and externally applied plaster for treating liver diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Huangqing Document name: payment instructions |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Huangqing Document name: Notice of entry |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Huangqing Document name: Notice of first review |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Huangqing Document name: Deemed as a notice of withdrawal |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |